- call +1-201-465-4211
- email sales@mrinsights.biz
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
Scope of the Report:
The worldwide market for Colorectal Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Colorectal Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Market Segment by Applications, can be divided into
Radiotherapy
Chemotherapy
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Colorectal Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Colorectal Cancer Drugs, with price, sales, revenue and global market share of Colorectal Cancer Drugs in 2017 and 2018.
Chapter 3, the Colorectal Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Colorectal Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Colorectal Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Colorectal Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Colorectal Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.3 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.4 BRAF or MEK Inhibitors
1.2.5 Tyrosine Kinase (TKI) Inhibitors
1.2.6 Immunomodulators
1.3 Market Analysis by Applications
1.3.1 Radiotherapy
1.3.2 Chemotherapy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AB Science
2.1.1 Business Overview
2.1.2 Colorectal Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AB Science Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Colorectal Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Array BioPharma
2.3.1 Business Overview
2.3.2 Colorectal Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Colorectal Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Colorectal Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Colorectal Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Elli Lilly
2.7.1 Business Overview
2.7.2 Colorectal Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Roch
2.8.1 Business Overview
2.8.2 Colorectal Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Roch Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hutchison MediPharma
2.9.1 Business Overview
2.9.2 Colorectal Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Merck & Co., Inc.
2.10.1 Business Overview
2.10.2 Colorectal Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Mologen
2.11.1 Business Overview
2.11.2 Colorectal Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mologen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Regeneron
2.12.1 Business Overview
2.12.2 Colorectal Cancer Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Regeneron Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Colorectal Cancer Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Sumitomo Dainippon
2.14.1 Business Overview
2.14.2 Colorectal Cancer Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Taiho Pharmaceutical
2.15.1 Business Overview
2.15.2 Colorectal Cancer Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Vaccinogen
2.16.1 Business Overview
2.16.2 Colorectal Cancer Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Colorectal Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Colorectal Cancer Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Colorectal Cancer Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Colorectal Cancer Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Colorectal Cancer Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Colorectal Cancer Drugs Market Analysis by Regions
4.1 Global Colorectal Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Colorectal Cancer Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Colorectal Cancer Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
4.5 South America Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
5 North America Colorectal Cancer Drugs by Country
5.1 North America Colorectal Cancer Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Colorectal Cancer Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Colorectal Cancer Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
6 Europe Colorectal Cancer Drugs by Country
6.1 Europe Colorectal Cancer Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Colorectal Cancer Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Colorectal Cancer Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
6.3 UK Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
6.4 France Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Colorectal Cancer Drugs by Country
7.1 Asia-Pacific Colorectal Cancer Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Colorectal Cancer Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Colorectal Cancer Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
7.5 India Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
8 South America Colorectal Cancer Drugs by Country
8.1 South America Colorectal Cancer Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Colorectal Cancer Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Colorectal Cancer Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Colorectal Cancer Drugs by Countries
9.1 Middle East and Africa Colorectal Cancer Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Colorectal Cancer Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Colorectal Cancer Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Colorectal Cancer Drugs Sales and Growth Rate (2014-2019)
10 Global Colorectal Cancer Drugs Market Segment by Type
10.1 Global Colorectal Cancer Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Colorectal Cancer Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Colorectal Cancer Drugs Revenue and Market Share by Type (2014-2019)
10.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Growth and Price
10.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Growth (2014-2019)
10.2.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Price (2014-2019)
10.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors Sales Growth and Price
10.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Sales Growth (2014-2019)
10.3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Price (2014-2019)
10.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Sales Growth and Price
10.4.1 Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Sales Growth (2014-2019)
10.4.2 Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Price (2014-2019)
10.5 BRAF or MEK Inhibitors Sales Growth and Price
10.5.1 Global BRAF or MEK Inhibitors Sales Growth (2014-2019)
10.5.2 Global BRAF or MEK Inhibitors Price (2014-2019)
10.6 Tyrosine Kinase (TKI) Inhibitors Sales Growth and Price
10.6.1 Global Tyrosine Kinase (TKI) Inhibitors Sales Growth (2014-2019)
10.6.2 Global Tyrosine Kinase (TKI) Inhibitors Price (2014-2019)
10.7 Immunomodulators Sales Growth and Price
10.7.1 Global Immunomodulators Sales Growth (2014-2019)
10.7.2 Global Immunomodulators Price (2014-2019)
11 Global Colorectal Cancer Drugs Market Segment by Application
11.1 Global Colorectal Cancer Drugs Sales Market Share by Application (2014-2019)
11.2 Radiotherapy Sales Growth (2014-2019)
11.3 Chemotherapy Sales Growth (2014-2019)
12 Colorectal Cancer Drugs Market Forecast (2019-2024)
12.1 Global Colorectal Cancer Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Colorectal Cancer Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Colorectal Cancer Drugs Market Forecast (2019-2024)
12.2.2 Europe Colorectal Cancer Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Colorectal Cancer Drugs Market Forecast (2019-2024)
12.2.4 South America Colorectal Cancer Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Colorectal Cancer Drugs Market Forecast (2019-2024)
12.3 Colorectal Cancer Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Colorectal Cancer Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Colorectal Cancer Drugs Market Share Forecast by Type (2019-2024)
12.4 Colorectal Cancer Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Colorectal Cancer Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Colorectal Cancer Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Colorectal Cancer Drugs Picture
Table Product Specifications of Colorectal Cancer Drugs
Figure Global Sales Market Share of Colorectal Cancer Drugs by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
